Be in the know. 22 key reads for Tuesday…

  1. Deals Are Creeping Back. Don’t Expect a Surge Just Yet. (barrons)
  2. Rangers’ Jacob Trouba delivers helmet-launching hit, dominates ensuing fight (nypost)
  3. The Market’s Breadth Is Improving as More Stocks Join Rally (wsj)
  4. CVS Nears Deal for Oak Street Health. The Sector Could Be Hot for M&A in 2023. (barrons)
  5. How the U.S. dollar could put this stock-market rally to a big test (marketwatch)
  6. Pfizer Is Moving Beyond Covid. Why Its Stock Is a Buy. (barrons)
  7. Biotech Stocks Will Mean a Big Year for Deals. Who Could Benefit. (barrons)
  8. The IPO market froze in 2022. Here’s what’s needed for it to thaw in the new year (marketwatch)
  9. Illumina Attracts Challengers for DNA Sequencing Ahead of Earnings (barrons)
  10. Housing Market Shows Signs of Thawing (wsj)
  11. Boeing plans to cut about 2,000 finance and HR jobs in 2023 (nypost)
  12. Inflation-battered shoppers turn to dollar stores for groceries (nypost)
  13. China’s richest ‘will keep buying luxury goods’ as middle classes tighten belt (scmp)
  14. Indonesia may raise nearly US$2 billion from 3 state company IPOs (scmp)
  15. Balloon Pops Blinken’s Visit, For Now (chinalastnight)
  16. Google unveils ChatGPT rival Bard, AI search plans in battle with Microsoft (reuters)
  17. JPMorgan’s Kolanovic Calls Latest Stock Rally a Bear-Market Trap (yahoo)
  18. These Are the Top 10 Holdings of Carl Icahn (247wallst)
  19. Can This Billionaire Drive Lotus Better Than Richard Gere? (bloomberg)
  20. What will TV look like in three years? These industry insiders share their predictions (cnbc)
  21. Trader Positioning Ahead Of Powell Hints At Another Delta Squeeze (zerohedge)
  22. Adani Companies Report Profits, Easing Market Rout (wsj)